Portfolio News

Agilent even finished the acquisition of Cobalt Light Systems, boosting their customer value proposition and offering with immediate entry into the ...

read more

The agreement – a £2 million two-year collaboration co-funded by Innovate UK – is to explore a next generation gene and cell therapy manufacturing platform for clinical and commercial applications. London, UK – 11 August 2017: Oxford BioMedica plc (“Oxford BioMedica” or “the Group”) (LSE:OXB), a leading gene and cell therapy group, has announced it has […] The post Synthace collaborates with Oxford BioMedica, Cell and Gene Therapy Catapult and Stratophase appeared first on Synthace Limited.

read more

But few will realise the firm behind the device which scans liquids and gels is based in Harwell. Cobalt Light Systems was snapped up by US ...

read more

CHAIN welcomes to its Board of Directors the recent appointment of Dr Mike McDonald and Peter McPartland as Non-Executive Directors. The appointments follow CHAIN’s successful seed investment round, led by Rainbow Seed Fund, earlier this year. Dr McDonald, a physician, brings 30 years of experience in US and European drug development. He has leadership and […]

read more

Smaller, agile projects will beat the large international collaborations like ITER to nuclear fusion. Nuclear fusion – the energy released when atomic nuclei merge – offers the potential for essentially limitless energy, without releasing greenhouse gases or creating dangerous nuclear waste, as nuclear fission does. It happens in stars such as our sun. We may […]

read more

1 2 3 5